ArticleHealth & justice2025
Barriers, beliefs, and biomedical prevention: a qualitative study of PrEP among justice-involved peripregnant women who use drugs.
Article in Health & justice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPeripregnant women who use drugs and are involved in the criminal legal system (CLS) face elevated risks of human immunodeficiency virus (HIV) acquisition due to overlapping vulnerabilities, including sexual violence, structural instability, and limited access to preventive healthcare. The unique needs of this population are routinely overlooked in both clinical practice and research. This qualitative study explores peripregnant women's perspectives on HIV risk, attitudes toward pre-exposure prophylaxis (PrEP), and opportunities for PrEP programming in jail settings and during pregnancy.
methodsWe conducted semi-structured qualitative interviews with 27 women in Miami-Dade County who met the following criteria: (1) peripregnancy experience, (2) history of drug use and CLS involvement, and (3) HIV-negative status. Participants were recruited through community-based outreach. Data collection was grounded in trauma-informed methods and community partnership. Data were transcribed and examined through a reflexive thematic analysis, employing a general inductive methodology. Coding was performed through an iterative process by an interdisciplinary team with diverse backgrounds.
resultsThere are five major themes: (1) perceptions of HIV risk and risk reduction strategies; (2) knowledge and attitudes toward PrEP; (3) preferences for PrEP delivery modalities; (4) PrEP programming in jail; and (5) perspectives on PrEP use during pregnancy. Women generally viewed PrEP positively, especially long-acting formulations like injectables and implantable devices (in development). However, they also expressed concerns about adherence, stigma, drug interactions, and fetal safety. Jail was identified as a key site for intervention, though participants emphasized the need for confidentiality and robust education.
conclusionsFindings underscore the urgency of designing patient-informed, context-responsive PrEP interventions that center the lived realities of CLS-involved peripregnant women who use drugs. Prioritizing long-acting PrEP options and integrating services into jail and community-based settings rooted in trauma-informed care and privacy protections can enhance uptake. These strategies are essential to reducing HIV incidence and advancing the goals of the Ending the HIV Epidemic (EHE) initiative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.